Clinical Trials Directory

Trials / Completed

CompletedNCT02395991

Evaluation of Transient Dyspnea During Gadoxetic Acid Enhanced Multiphasic Liver MRI

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to observe transient dyspnea pattern after Gd-EOB-DTPA administration by obtaining continuous dynamic T1 weighted image data.

Conditions

Interventions

TypeNameDescription
DRUGgadoxetic acidstandard dose of gadoxetic acid (0.025mmol/kg) intravenous administration
OTHERMagnetic resonance imaging (MRI)Dynamic T1 weighted sequence consist of precontrast, arterial, portal, transitional and hepatobiliary phases. precontrast, arterial and portal phases (prior to contrast media injection to 60 seconds after contrast media injection) are obtained continuously in free-breathing state. Transitional and hepatobiliary phases are obtained in breath-hold state.

Timeline

Start date
2015-04-01
Primary completion
2016-10-01
Completion
2018-02-01
First posted
2015-03-24
Last updated
2021-05-26
Results posted
2021-05-26

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02395991. Inclusion in this directory is not an endorsement.

Evaluation of Transient Dyspnea During Gadoxetic Acid Enhanced Multiphasic Liver MRI (NCT02395991) · Clinical Trials Directory